Prestige Brands Holdings Inc. head Matthew Mannelly looks at recent pharma industry mergers and sees not only industry consolidation, but also the likelihood of some consumer health care properties becoming the firm’s next acquisition targets.
Prestige Brands was the No. 6 OTC drug firm in North America with $1 billion sales for 2013 when including...